Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972022
2.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Int J Gynecol Cancer
; 33(9): 1458-1463, 2023 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666539
3.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295818
4.
Metastatic Malignant Ovarian Steroid Cell Tumor: A Case Report and Review of the Literature.
Case Rep Obstet Gynecol
; 2016: 6184573, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27375912